NCT03229421

Brief Summary

The purpose of this study is to determine whether any diagnostic patterns exist in the symptom presentation of Zika Virus.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 6, 2017

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

February 4, 2019

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

July 18, 2017

Last Update Submit

January 31, 2019

Conditions

Zika Virus Symptoms and the Associated Exanthema

Keywords

Zika Virus

Outcome Measures

Primary Outcomes (1)

  • Number of days with specific symptoms

    Number of days reported experiencing specific symptoms due to Zika Virus infection and and associated characteristics such as location and intensity

    20 minutes

Secondary Outcomes (1)

  • Frequency measures of initial clinical presentations

    20 minutes

Interventions

SurveyOTHER

18 question symptom assessment tool including non-identifying demographic information questions.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults 18 y/o with confirmed zika virus diagnosis

You may qualify if:

  • Adults aged 18 years and older presenting with febrile illness and rash

You may not qualify if:

  • Patients aged 17 years or younger

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pontificia Universidad Catolica Madre y Maestra, Departamento de Medicina

Santo Domingo, Illinois, Dominican Republic

Location

MeSH Terms

Conditions

Zika Virus Infection

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus Infections

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Roopal V. Kundu, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2017

First Posted

July 25, 2017

Study Start

July 6, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

February 4, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations

DO(1)